Global Liver Disease Drugs Market Executive Summary
Liver disease treatment aids in the excretion of cholesterol and hormones increasing bile production and enzyme activation. Poor eating habits and unhealthy lifestyle causes weight gain further leading to obesity. Obesity, followed by alcoholism, is the major cause of fatty liver disease in adults. Fat accumulates in the liver as a result of being overweight or obese. This causes liver scarring and chronic inflammation.
Market Size and Key Findings
The Global Liver Disease Drugs Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Liver Disease Drugs Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
The rising geriatric population, which is susceptible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting market growth. various technological advancements, such as the development of the bioartificial liver, are providing an impetus to market growth.
Market Restraints
Stringent regulatory approval for novel drugs & vaccines and resistance to certain antiviral drugs restrain the market growth.
Competitive Landscape
Key Players
Major players in Liver Disease Drugs Market are Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.
TABLE OF CONTENT
1. Report Description of the Global Liver Disease Drugs
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Liver Disease Drugs Executive Summary
2.1 Global Liver Disease Drugs – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Liver Disease Drugs
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Liver Disease Drugs Segmentation
4.1Treatment type
4.1.1 Antiviral Drugs
4.1.2 Immunosuppressants
4.1.3 Vaccines
4.1.4 Immunoglobulins
4.1.5 Corticosteroids
4.1.6 Targeted Therapy
4.1.7 Chemotherapy
4.2 Disease type
4.2.1 Hepatitis
4.2.2 Autoimmune Diseases
4.2.3 Non-alcoholic Fatty Liver Disease (NAFLD)
4.2.4 Cancer
4.2.5 Genetic Disorders
4.2.6 Others
4.3 End-user
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Centers
4.3.3 Others
5. Global Liver Disease Drugs Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Liver Disease Drugs
9. Factors Driving Future Growth
9.1 New Trends and Development Global Liver Disease Drugs
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Liver Disease Drugs Market Segmentation
Treatment type
Antiviral Drugs
Immunosuppressants
Vaccines
Immunoglobulins
Corticosteroids
Targeted Therapy
Chemotherapy
Disease type
Hepatitis
Autoimmune Diseases
Non-alcoholic Fatty Liver Disease (NAFLD)
Cancer
Genetic Disorders
Others
End-user
Hospitals
Ambulatory Surgical Centers
Others
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
